Mild stroke: safety and outcome in patients receiving thrombolysis
Objectives The aim of this study was to compare the short‐term clinical outcome of patients with acute cerebral ischemia and mild symptoms receiving rt‐PA with that of patients with acute cerebral ischemia and mild symptoms not treated with rt‐PA, and to investigate the frequency of symptomatic intr...
Gespeichert in:
Veröffentlicht in: | Acta neurologica Scandinavica 2014-04, Vol.129 (s198), p.37-40 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 40 |
---|---|
container_issue | s198 |
container_start_page | 37 |
container_title | Acta neurologica Scandinavica |
container_volume | 129 |
creator | Logallo, N. Kvistad, C. E. Naess, H. Waje-Andreassen, U. Thomassen, L. |
description | Objectives
The aim of this study was to compare the short‐term clinical outcome of patients with acute cerebral ischemia and mild symptoms receiving rt‐PA with that of patients with acute cerebral ischemia and mild symptoms not treated with rt‐PA, and to investigate the frequency of symptomatic intracranial hemorrhage (sICH) in these patients.
Materials and methods
All patients with confirmed ischemic stroke/TIA and mild symptoms were included. Mild symptoms were defined as NIHSS score ≤5 on admission. Functional outcome was assessed with modified Rankin Scale (mRS) at day 7 or at earlier discharge. Excellent outcome was defined as mRS = 0. sICH was defined according to both NINDS and ECASS III criteria.
Results
Of 2753 patients with confirmed ischemic stroke/TIA admitted between February 2006 and February 2013, 966 (35.3%) were excluded because of having admission NIHSS >5. A total of 1791 patients presented with mild symptoms on admission (NIHSS ≤5), of which 158 (8.8%) patients received rt‐PA. Treatment with rt‐PA and early admission were independently associated with excellent outcome. Higher NIHSS score on admission and prior ischemic stroke were independently associated with poor outcome. Three (1.9%) sICH were diagnosed in rt‐PA‐treated patients and one (0.1%) in patients not receiving rt‐PA.
Conclusions
This study highlights the efficacy of rt‐PA in patients with acute cerebral ischemia presenting with mild symptoms and confirms the low‐risk profile of this treatment. |
doi_str_mv | 10.1111/ane.12235 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1504454746</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3235139881</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4965-b3d7257dc1ac17d61b08efdb847a9e3035b53ecda30543bd938286af70cdfc403</originalsourceid><addsrcrecordid>eNp1kE1P3DAQhq2KqiwfB_4AisQFDgF_xklvdLVdKgE90ApulmNPqCGJt3YC7L-vYZc9IHUuo5GeeTTzInRA8ClJdaZ7OCWUMvEJTUiBcY455ltogjEmecEI30Y7MT6kiUrOv6BtykVZCiwm6NuVa20Wh-Af4WsWdQPDMtO9zfw4GN9B5vpsoQcH_RCzAAbck-vvs-FP8F3t22V0cQ99bnQbYX_dd9Hv77Nf04v88uf8x_T8Mje8KkReMyupkNYQbYi0BalxCY2tSy51BQwzUQsGxmqGBWe1rVhJy0I3EhvbGI7ZLjpeeRfB_x0hDqpz0UDbpvf9GBURmHPBJS8SevQBffBj6NN1rxSTtKgqmaiTFWWCjzFAoxbBdTosFcHqNViVzOot2MQero1j3YHdkO9JJuBsBTy7Fpb_N6nz69m7Ml9tuDjAy2ZDh0dVSCaFur2eK0pvyoqzqbpj_wA7CY_A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1503726997</pqid></control><display><type>article</type><title>Mild stroke: safety and outcome in patients receiving thrombolysis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Logallo, N. ; Kvistad, C. E. ; Naess, H. ; Waje-Andreassen, U. ; Thomassen, L.</creator><creatorcontrib>Logallo, N. ; Kvistad, C. E. ; Naess, H. ; Waje-Andreassen, U. ; Thomassen, L.</creatorcontrib><description>Objectives
The aim of this study was to compare the short‐term clinical outcome of patients with acute cerebral ischemia and mild symptoms receiving rt‐PA with that of patients with acute cerebral ischemia and mild symptoms not treated with rt‐PA, and to investigate the frequency of symptomatic intracranial hemorrhage (sICH) in these patients.
Materials and methods
All patients with confirmed ischemic stroke/TIA and mild symptoms were included. Mild symptoms were defined as NIHSS score ≤5 on admission. Functional outcome was assessed with modified Rankin Scale (mRS) at day 7 or at earlier discharge. Excellent outcome was defined as mRS = 0. sICH was defined according to both NINDS and ECASS III criteria.
Results
Of 2753 patients with confirmed ischemic stroke/TIA admitted between February 2006 and February 2013, 966 (35.3%) were excluded because of having admission NIHSS >5. A total of 1791 patients presented with mild symptoms on admission (NIHSS ≤5), of which 158 (8.8%) patients received rt‐PA. Treatment with rt‐PA and early admission were independently associated with excellent outcome. Higher NIHSS score on admission and prior ischemic stroke were independently associated with poor outcome. Three (1.9%) sICH were diagnosed in rt‐PA‐treated patients and one (0.1%) in patients not receiving rt‐PA.
Conclusions
This study highlights the efficacy of rt‐PA in patients with acute cerebral ischemia presenting with mild symptoms and confirms the low‐risk profile of this treatment.</description><identifier>ISSN: 0001-6314</identifier><identifier>EISSN: 1600-0404</identifier><identifier>EISSN: 1600-5449</identifier><identifier>DOI: 10.1111/ane.12235</identifier><identifier>PMID: 24588505</identifier><identifier>CODEN: ANRSAS</identifier><language>eng</language><publisher>Denmark: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Brain Ischemia - complications ; Brain Ischemia - drug therapy ; Female ; Fibrinolytic Agents - adverse effects ; Fibrinolytic Agents - therapeutic use ; Humans ; intravenous thrombolysis ; Ischemia ; Male ; Medical research ; Middle Aged ; mild stroke ; Stroke ; Stroke - complications ; Stroke - drug therapy ; stroke epidemiology ; stroke outcome ; Thrombolytic Therapy - adverse effects ; Time Factors ; Tissue Plasminogen Activator - adverse effects ; Tissue Plasminogen Activator - therapeutic use ; Treatment Outcome</subject><ispartof>Acta neurologica Scandinavica, 2014-04, Vol.129 (s198), p.37-40</ispartof><rights>2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd</rights><rights>2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.</rights><rights>Copyright © 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4965-b3d7257dc1ac17d61b08efdb847a9e3035b53ecda30543bd938286af70cdfc403</citedby><cites>FETCH-LOGICAL-c4965-b3d7257dc1ac17d61b08efdb847a9e3035b53ecda30543bd938286af70cdfc403</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24588505$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Logallo, N.</creatorcontrib><creatorcontrib>Kvistad, C. E.</creatorcontrib><creatorcontrib>Naess, H.</creatorcontrib><creatorcontrib>Waje-Andreassen, U.</creatorcontrib><creatorcontrib>Thomassen, L.</creatorcontrib><title>Mild stroke: safety and outcome in patients receiving thrombolysis</title><title>Acta neurologica Scandinavica</title><addtitle>Acta Neurol Scand</addtitle><description>Objectives
The aim of this study was to compare the short‐term clinical outcome of patients with acute cerebral ischemia and mild symptoms receiving rt‐PA with that of patients with acute cerebral ischemia and mild symptoms not treated with rt‐PA, and to investigate the frequency of symptomatic intracranial hemorrhage (sICH) in these patients.
Materials and methods
All patients with confirmed ischemic stroke/TIA and mild symptoms were included. Mild symptoms were defined as NIHSS score ≤5 on admission. Functional outcome was assessed with modified Rankin Scale (mRS) at day 7 or at earlier discharge. Excellent outcome was defined as mRS = 0. sICH was defined according to both NINDS and ECASS III criteria.
Results
Of 2753 patients with confirmed ischemic stroke/TIA admitted between February 2006 and February 2013, 966 (35.3%) were excluded because of having admission NIHSS >5. A total of 1791 patients presented with mild symptoms on admission (NIHSS ≤5), of which 158 (8.8%) patients received rt‐PA. Treatment with rt‐PA and early admission were independently associated with excellent outcome. Higher NIHSS score on admission and prior ischemic stroke were independently associated with poor outcome. Three (1.9%) sICH were diagnosed in rt‐PA‐treated patients and one (0.1%) in patients not receiving rt‐PA.
Conclusions
This study highlights the efficacy of rt‐PA in patients with acute cerebral ischemia presenting with mild symptoms and confirms the low‐risk profile of this treatment.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Brain Ischemia - complications</subject><subject>Brain Ischemia - drug therapy</subject><subject>Female</subject><subject>Fibrinolytic Agents - adverse effects</subject><subject>Fibrinolytic Agents - therapeutic use</subject><subject>Humans</subject><subject>intravenous thrombolysis</subject><subject>Ischemia</subject><subject>Male</subject><subject>Medical research</subject><subject>Middle Aged</subject><subject>mild stroke</subject><subject>Stroke</subject><subject>Stroke - complications</subject><subject>Stroke - drug therapy</subject><subject>stroke epidemiology</subject><subject>stroke outcome</subject><subject>Thrombolytic Therapy - adverse effects</subject><subject>Time Factors</subject><subject>Tissue Plasminogen Activator - adverse effects</subject><subject>Tissue Plasminogen Activator - therapeutic use</subject><subject>Treatment Outcome</subject><issn>0001-6314</issn><issn>1600-0404</issn><issn>1600-5449</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1P3DAQhq2KqiwfB_4AisQFDgF_xklvdLVdKgE90ApulmNPqCGJt3YC7L-vYZc9IHUuo5GeeTTzInRA8ClJdaZ7OCWUMvEJTUiBcY455ltogjEmecEI30Y7MT6kiUrOv6BtykVZCiwm6NuVa20Wh-Af4WsWdQPDMtO9zfw4GN9B5vpsoQcH_RCzAAbck-vvs-FP8F3t22V0cQ99bnQbYX_dd9Hv77Nf04v88uf8x_T8Mje8KkReMyupkNYQbYi0BalxCY2tSy51BQwzUQsGxmqGBWe1rVhJy0I3EhvbGI7ZLjpeeRfB_x0hDqpz0UDbpvf9GBURmHPBJS8SevQBffBj6NN1rxSTtKgqmaiTFWWCjzFAoxbBdTosFcHqNViVzOot2MQero1j3YHdkO9JJuBsBTy7Fpb_N6nz69m7Ml9tuDjAy2ZDh0dVSCaFur2eK0pvyoqzqbpj_wA7CY_A</recordid><startdate>201404</startdate><enddate>201404</enddate><creator>Logallo, N.</creator><creator>Kvistad, C. E.</creator><creator>Naess, H.</creator><creator>Waje-Andreassen, U.</creator><creator>Thomassen, L.</creator><general>Blackwell Publishing Ltd</general><general>Hindawi Limited</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201404</creationdate><title>Mild stroke: safety and outcome in patients receiving thrombolysis</title><author>Logallo, N. ; Kvistad, C. E. ; Naess, H. ; Waje-Andreassen, U. ; Thomassen, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4965-b3d7257dc1ac17d61b08efdb847a9e3035b53ecda30543bd938286af70cdfc403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Brain Ischemia - complications</topic><topic>Brain Ischemia - drug therapy</topic><topic>Female</topic><topic>Fibrinolytic Agents - adverse effects</topic><topic>Fibrinolytic Agents - therapeutic use</topic><topic>Humans</topic><topic>intravenous thrombolysis</topic><topic>Ischemia</topic><topic>Male</topic><topic>Medical research</topic><topic>Middle Aged</topic><topic>mild stroke</topic><topic>Stroke</topic><topic>Stroke - complications</topic><topic>Stroke - drug therapy</topic><topic>stroke epidemiology</topic><topic>stroke outcome</topic><topic>Thrombolytic Therapy - adverse effects</topic><topic>Time Factors</topic><topic>Tissue Plasminogen Activator - adverse effects</topic><topic>Tissue Plasminogen Activator - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Logallo, N.</creatorcontrib><creatorcontrib>Kvistad, C. E.</creatorcontrib><creatorcontrib>Naess, H.</creatorcontrib><creatorcontrib>Waje-Andreassen, U.</creatorcontrib><creatorcontrib>Thomassen, L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Acta neurologica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Logallo, N.</au><au>Kvistad, C. E.</au><au>Naess, H.</au><au>Waje-Andreassen, U.</au><au>Thomassen, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mild stroke: safety and outcome in patients receiving thrombolysis</atitle><jtitle>Acta neurologica Scandinavica</jtitle><addtitle>Acta Neurol Scand</addtitle><date>2014-04</date><risdate>2014</risdate><volume>129</volume><issue>s198</issue><spage>37</spage><epage>40</epage><pages>37-40</pages><issn>0001-6314</issn><eissn>1600-0404</eissn><eissn>1600-5449</eissn><coden>ANRSAS</coden><abstract>Objectives
The aim of this study was to compare the short‐term clinical outcome of patients with acute cerebral ischemia and mild symptoms receiving rt‐PA with that of patients with acute cerebral ischemia and mild symptoms not treated with rt‐PA, and to investigate the frequency of symptomatic intracranial hemorrhage (sICH) in these patients.
Materials and methods
All patients with confirmed ischemic stroke/TIA and mild symptoms were included. Mild symptoms were defined as NIHSS score ≤5 on admission. Functional outcome was assessed with modified Rankin Scale (mRS) at day 7 or at earlier discharge. Excellent outcome was defined as mRS = 0. sICH was defined according to both NINDS and ECASS III criteria.
Results
Of 2753 patients with confirmed ischemic stroke/TIA admitted between February 2006 and February 2013, 966 (35.3%) were excluded because of having admission NIHSS >5. A total of 1791 patients presented with mild symptoms on admission (NIHSS ≤5), of which 158 (8.8%) patients received rt‐PA. Treatment with rt‐PA and early admission were independently associated with excellent outcome. Higher NIHSS score on admission and prior ischemic stroke were independently associated with poor outcome. Three (1.9%) sICH were diagnosed in rt‐PA‐treated patients and one (0.1%) in patients not receiving rt‐PA.
Conclusions
This study highlights the efficacy of rt‐PA in patients with acute cerebral ischemia presenting with mild symptoms and confirms the low‐risk profile of this treatment.</abstract><cop>Denmark</cop><pub>Blackwell Publishing Ltd</pub><pmid>24588505</pmid><doi>10.1111/ane.12235</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0001-6314 |
ispartof | Acta neurologica Scandinavica, 2014-04, Vol.129 (s198), p.37-40 |
issn | 0001-6314 1600-0404 1600-5449 |
language | eng |
recordid | cdi_proquest_miscellaneous_1504454746 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adult Aged Aged, 80 and over Brain Ischemia - complications Brain Ischemia - drug therapy Female Fibrinolytic Agents - adverse effects Fibrinolytic Agents - therapeutic use Humans intravenous thrombolysis Ischemia Male Medical research Middle Aged mild stroke Stroke Stroke - complications Stroke - drug therapy stroke epidemiology stroke outcome Thrombolytic Therapy - adverse effects Time Factors Tissue Plasminogen Activator - adverse effects Tissue Plasminogen Activator - therapeutic use Treatment Outcome |
title | Mild stroke: safety and outcome in patients receiving thrombolysis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T15%3A02%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mild%20stroke:%20safety%20and%20outcome%20in%20patients%20receiving%20thrombolysis&rft.jtitle=Acta%20neurologica%20Scandinavica&rft.au=Logallo,%20N.&rft.date=2014-04&rft.volume=129&rft.issue=s198&rft.spage=37&rft.epage=40&rft.pages=37-40&rft.issn=0001-6314&rft.eissn=1600-0404&rft.coden=ANRSAS&rft_id=info:doi/10.1111/ane.12235&rft_dat=%3Cproquest_cross%3E3235139881%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1503726997&rft_id=info:pmid/24588505&rfr_iscdi=true |